HUP9900801A2 - Kortikoszteroidokat tartalmazó gyógyszerkészítmények - Google Patents

Kortikoszteroidokat tartalmazó gyógyszerkészítmények

Info

Publication number
HUP9900801A2
HUP9900801A2 HU9900801A HUP9900801A HUP9900801A2 HU P9900801 A2 HUP9900801 A2 HU P9900801A2 HU 9900801 A HU9900801 A HU 9900801A HU P9900801 A HUP9900801 A HU P9900801A HU P9900801 A2 HUP9900801 A2 HU P9900801A2
Authority
HU
Hungary
Prior art keywords
betamethasone
valerate
corticosteroid
pharmaceutical composition
containing pharmaceutical
Prior art date
Application number
HU9900801A
Other languages
English (en)
Inventor
Anthony Richard Baker
Neil Graham Halls
Julie Irene Jones
Peter Marriott
Peter Watmough
Original Assignee
Medeva Plc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10770568&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HUP9900801(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Medeva Plc. filed Critical Medeva Plc.
Publication of HUP9900801A2 publication Critical patent/HUP9900801A2/hu
Publication of HUP9900801A3 publication Critical patent/HUP9900801A3/hu
Publication of HU228890B1 publication Critical patent/HU228890B1/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A61K9/122—Foams; Dry foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics

Abstract

A találmány tárgyát tővábbfejlesztett készítmények képezik, amelyekkőrtikőszterőid hatóanyagők helyi, a beteg bőrén való alkalmazásraszőlgálnak. A találmány szerinti készítmények különösen előnyösek abetametazőn és származékai (pl. betametazőn-benzőát, betametazőn-diprőpiőnát és betametazőn-valerát) emberi bőrre való helyialkalmazása esetén. Különösen kitüntetett a valerát alkalmazása,főként a pszőriázis kezelésében. A találmány szerinti készítmény őlyantartályba zárható és ebből szétősztható, amely a hajtógáz nyőmásávalszemben stabil és megfelelő szelep/fúvóka rendszerrel rendelkezik akészítmény hab alakban, nyőmás alatt való kibőcsátására. ŕ
HU9900801A 1995-03-03 1996-03-01 Corticosteroid-containing foam and use thereof HU228890B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9504265.1A GB9504265D0 (en) 1995-03-03 1995-03-03 Corticosteroid-containing pharmaceutical composition
PCT/GB1996/000490 WO1996027376A1 (en) 1995-03-03 1996-03-01 Corticosteroid-containing pharmaceutical composition

Publications (3)

Publication Number Publication Date
HUP9900801A2 true HUP9900801A2 (hu) 1999-07-28
HUP9900801A3 HUP9900801A3 (en) 1999-11-29
HU228890B1 HU228890B1 (en) 2013-06-28

Family

ID=10770568

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9900801A HU228890B1 (en) 1995-03-03 1996-03-01 Corticosteroid-containing foam and use thereof

Country Status (21)

Country Link
US (3) US6126920A (hu)
EP (1) EP0813413B1 (hu)
JP (1) JP4557310B2 (hu)
KR (1) KR100427492B1 (hu)
CN (1) CN1082817C (hu)
AT (1) ATE253367T1 (hu)
AU (1) AU709320B2 (hu)
BR (1) BR9607687A (hu)
CA (1) CA2214436C (hu)
CZ (1) CZ285913B6 (hu)
DE (1) DE69630593T2 (hu)
DK (1) DK0813413T3 (hu)
ES (1) ES2210349T3 (hu)
GB (1) GB9504265D0 (hu)
HU (1) HU228890B1 (hu)
MX (1) MX9706698A (hu)
NZ (1) NZ302727A (hu)
PL (1) PL183730B1 (hu)
PT (1) PT813413E (hu)
SK (1) SK283049B6 (hu)
WO (1) WO1996027376A1 (hu)

Families Citing this family (101)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPN814496A0 (en) * 1996-02-19 1996-03-14 Monash University Dermal penetration enhancer
FR2745716B1 (fr) * 1996-03-07 1998-04-17 Oreal Emulsions huile-dans-eau moussantes pressurisables ultrafines
AUPO347396A0 (en) * 1996-11-04 1996-12-05 Medical Innovations Limited Synergistic gold-containing compositions
AUPO983897A0 (en) 1997-10-17 1997-11-06 Soltec Research Pty Ltd Topical antifungal composition
AUPP310798A0 (en) 1998-04-22 1998-05-14 Soltec Research Pty Ltd Vehicle system for a composition comprising a piperidinopyrimidine derivative
FR2761600B1 (fr) * 1998-06-19 2000-03-31 Oreal Composition moussante pour le lavage et le traitement des cheveux et/ou du cuir chevelu a base d'un principe actif, d'un tensioactif anionique, d'un tensioactif amphotere et d'un agent propenetrant
AUPP583198A0 (en) 1998-09-11 1998-10-01 Soltec Research Pty Ltd Mousse composition
US8263580B2 (en) 1998-09-11 2012-09-11 Stiefel Research Australia Pty Ltd Vitamin formulation
US6389455B1 (en) * 1998-09-22 2002-05-14 Richard C. Fuisz Method and apparatus for bouncing electronic messages
US6358541B1 (en) 2000-05-03 2002-03-19 David S. Goodman Topical preparation for the treatment of hair loss
US8512718B2 (en) 2000-07-03 2013-08-20 Foamix Ltd. Pharmaceutical composition for topical application
TW523409B (en) * 2000-09-15 2003-03-11 Baxter Int Container for inhalation anesthetic
AUPR048600A0 (en) * 2000-10-02 2000-10-26 Soltec Research Pty Ltd Pharmaceutical vehicle
ES2589077T3 (es) * 2002-06-25 2016-11-10 Acrux Dds Pty Ltd Control de la tasa de administración transdérmica usando composiciones farmacéuticas amorfas
US20050181032A1 (en) * 2002-06-25 2005-08-18 Acrux Dds Pty Ltd. Metastable pharmaceutical compositions
US20050186141A1 (en) * 2002-06-25 2005-08-25 Acrux Dds Pty Ltd. Transdermal aerosol compositions
IL152486A0 (en) 2002-10-25 2003-05-29 Meir Eini Alcohol-free cosmetic and pharmaceutical foam carrier
WO2004037225A2 (en) * 2002-10-25 2004-05-06 Foamix Ltd. Cosmetic and pharmaceutical foam
US7704518B2 (en) 2003-08-04 2010-04-27 Foamix, Ltd. Foamable vehicle and pharmaceutical compositions thereof
US9265725B2 (en) 2002-10-25 2016-02-23 Foamix Pharmaceuticals Ltd. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
US8900554B2 (en) 2002-10-25 2014-12-02 Foamix Pharmaceuticals Ltd. Foamable composition and uses thereof
US8119109B2 (en) 2002-10-25 2012-02-21 Foamix Ltd. Foamable compositions, kits and methods for hyperhidrosis
US8119150B2 (en) * 2002-10-25 2012-02-21 Foamix Ltd. Non-flammable insecticide composition and uses thereof
US9668972B2 (en) 2002-10-25 2017-06-06 Foamix Pharmaceuticals Ltd. Nonsteroidal immunomodulating kit and composition and uses thereof
US8486376B2 (en) 2002-10-25 2013-07-16 Foamix Ltd. Moisturizing foam containing lanolin
US7700076B2 (en) 2002-10-25 2010-04-20 Foamix, Ltd. Penetrating pharmaceutical foam
US9211259B2 (en) 2002-11-29 2015-12-15 Foamix Pharmaceuticals Ltd. Antibiotic kit and composition and uses thereof
US7820145B2 (en) 2003-08-04 2010-10-26 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
US20080138296A1 (en) 2002-10-25 2008-06-12 Foamix Ltd. Foam prepared from nanoemulsions and uses
US10117812B2 (en) 2002-10-25 2018-11-06 Foamix Pharmaceuticals Ltd. Foamable composition combining a polar solvent and a hydrophobic carrier
ES2637956T3 (es) * 2003-01-24 2017-10-18 Stiefel Research Australia Pty Ltd Espuma farmacéutica
US7575739B2 (en) * 2003-04-28 2009-08-18 Foamix Ltd. Foamable iodine composition
US7186416B2 (en) * 2003-05-28 2007-03-06 Stiefel Laboratories, Inc. Foamable pharmaceutical compositions and methods for treating a disorder
US20050037040A1 (en) * 2003-08-13 2005-02-17 Moshe Arkin Topical compositions of urea and ammonium lactate
US20050042182A1 (en) * 2003-08-13 2005-02-24 Moshe Arkin Topical compositions of urea
US20050036953A1 (en) * 2003-08-13 2005-02-17 Moshe Arkin Topical compositions of ammonium lactate
US20050042268A1 (en) * 2003-07-16 2005-02-24 Chaim Aschkenasy Pharmaceutical composition and method for transdermal drug delivery
US20050014823A1 (en) * 2003-07-17 2005-01-20 Soderlund Patrick L. Topical anesthetic composition and method of administration
US8486374B2 (en) 2003-08-04 2013-07-16 Foamix Ltd. Hydrophilic, non-aqueous pharmaceutical carriers and compositions and uses
US8795693B2 (en) 2003-08-04 2014-08-05 Foamix Ltd. Compositions with modulating agents
CN1856294A (zh) 2003-08-25 2006-11-01 弗米克斯有限公司 渗透性药物泡沫
US20050069499A1 (en) * 2003-09-25 2005-03-31 Moshe Arkin Foamable compositions, processes of preparing same and uses thereof
US20060188449A1 (en) * 2003-10-03 2006-08-24 Jane Hirsh Topical aerosol foams
CA2548892C (en) * 2003-12-12 2015-10-27 Eran Eilat Compositions for treatment of ear disorders and methods of use thereof
US8940321B2 (en) 2003-12-12 2015-01-27 Otic Pharma Ltd. Compositions for treatment of ear disorders and methods of use thereof
US8003616B2 (en) * 2004-04-23 2011-08-23 Albert Rory J Composition for the treatment of ear infections and method
US20060057075A1 (en) * 2004-08-02 2006-03-16 Moshe Arkin Pharmaceutical and cosmeceutical wash-off mousse shampoo compositions, processes for preparing the same and uses thereof
US20060034779A1 (en) * 2004-08-02 2006-02-16 Agis Industries (1983) Ltd. Foamable compositions containing vitamin D3 analogues, processes for preparing same and methods of treatment utilizng same
JP2008540508A (ja) 2005-05-09 2008-11-20 フォーミックス エルティーディー． 起泡性ビヒクル及びその医薬組成物
WO2006130510A2 (en) 2005-05-27 2006-12-07 Taro Pharmaceuticals U.S.A., Inc. Stable liquid desoximethasone compositions with reduced oxidized impurity
NZ563560A (en) * 2005-06-01 2009-11-27 Stiefel Res Australia Pty Ltd Vitamin formulation for treating a dermatological skin disorder
US20100154146A1 (en) 2008-07-02 2010-06-24 S.C. Johnson & Son, Inc. Carpet decor and setting solution compositions
US8846154B2 (en) 2005-06-07 2014-09-30 S.C. Johnson & Son, Inc. Carpet décor and setting solution compositions
EP2100601B1 (en) 2005-10-24 2012-06-27 Precision Dermatology, Inc. Topical pharmaceutical foam composition
WO2008007224A2 (en) 2006-03-31 2008-01-17 Stiefel Research Australia Pty Ltd Foamable suspension gel
CN101484564B (zh) * 2006-07-06 2011-08-03 森特尼尔投资有限公司 对皮肤友好的广谱消毒组合物
GB2443161B (en) * 2006-10-28 2011-03-23 Nupharm Lab Ltd Clobetasol spray
GB2443162B (en) * 2006-10-28 2011-02-09 Nupharm Lab Ltd Betamethasone spray
US20080260655A1 (en) 2006-11-14 2008-10-23 Dov Tamarkin Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
FR2911781B1 (fr) 2007-01-26 2009-03-20 Fabre Pierre Dermo Cosmetique Emulsion dermatologique et procede de preparation
US8636982B2 (en) 2007-08-07 2014-01-28 Foamix Ltd. Wax foamable vehicle and pharmaceutical compositions thereof
US9439857B2 (en) 2007-11-30 2016-09-13 Foamix Pharmaceuticals Ltd. Foam containing benzoyl peroxide
WO2009090495A2 (en) 2007-12-07 2009-07-23 Foamix Ltd. Oil and liquid silicone foamable carriers and formulations
US8518376B2 (en) 2007-12-07 2013-08-27 Foamix Ltd. Oil-based foamable carriers and formulations
EP2242476A2 (en) 2008-01-14 2010-10-27 Foamix Ltd. Poloxamer foamable pharmaceutical compositions with active agents and/or therapeutic cells and uses
DE102008006394A1 (de) * 2008-01-28 2009-07-30 Beiersdorf Ag Verwendung von Wirkstoffkomplexen aus Panthenol, Glycerin, Citrat und/oder Bisabolol gegen Pollenallergien
US8652443B2 (en) * 2008-02-14 2014-02-18 Precision Dermatology, Inc. Foamable microemulsion compositions for topical administration
US9480691B1 (en) * 2009-01-20 2016-11-01 Hill Dermaceuticals, Inc. Topical liquid containing refined peanut oil for treating skin proliferation or inflammation disorders
WO2010125470A2 (en) 2009-04-28 2010-11-04 Foamix Ltd. Foamable vehicle and pharmaceutical compositions comprising aprotic polar solvents and uses thereof
AR073346A1 (es) * 2009-07-21 2010-11-03 Silva Pablo Cesar Composicion formadora de espuma para la generacion de senalizaciones de duracion temporal acotada
CA2769625C (en) 2009-07-29 2017-04-11 Foamix Ltd. Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses
CA2769677A1 (en) * 2009-07-29 2011-02-03 Foamix Ltd. Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses
EP3141246A1 (en) 2009-08-31 2017-03-15 Dr. Reddy's Laboratories Ltd. Topical formulations comprising a steroid
BR112012006756A2 (pt) * 2009-09-25 2016-05-17 Pharmasol Corp revestimentos para aplicação na superfície da pele
CN102686205A (zh) 2009-10-02 2012-09-19 弗艾米克斯有限公司 局部四环素组合物
US9849142B2 (en) 2009-10-02 2017-12-26 Foamix Pharmaceuticals Ltd. Methods for accelerated return of skin integrity and for the treatment of impetigo
US8174881B2 (en) 2009-11-24 2012-05-08 Micron Technology, Inc. Techniques for reducing disturbance in a semiconductor device
CN101810566B (zh) * 2009-11-26 2012-06-20 天津金耀集团有限公司 一种丁酸氢化可的松乳膏
PL2335675T3 (pl) 2009-12-10 2015-08-31 Neubourg Skin Care Gmbh & Co Kg Wolne od emulgatorów, stabilizowane polimerem formulacje pianki
EP2515874B1 (en) * 2009-12-22 2014-08-20 Leo Pharma A/S Calcipotriol monohydrate nanocrystals
CN103491778B (zh) 2010-04-13 2017-05-31 雷尔玛达治疗股份有限公司 1‑甲基‑n‑(2，6‑二甲苯基)‑2‑哌啶甲酰胺的皮肤用药物组合物及其使用方法
US8685381B2 (en) 2010-10-23 2014-04-01 Joel Schlessinger Topical base and active agent-containing compositions, and methods for improving and treating skin
US8968755B2 (en) 2010-10-23 2015-03-03 Joel Schlessinger Topical base and active agent-containing compositions, and methods for improving and treating skin
CA2834710A1 (en) * 2011-05-16 2012-11-22 Dale L. Pearlman Compositions and methods for the treatment of skin diseases
EP2734189B1 (en) 2011-07-20 2018-08-22 Perrigo Israel Pharmaceuticals Ltd. Topical oily foam compositions
US8580286B2 (en) 2012-03-16 2013-11-12 Dale L. Pearlman Compositions and methods for the treatment of skin diseases
US9561240B2 (en) 2012-12-26 2017-02-07 Otic Pharma Ltd. Foamable otic pharmaceutical compositions
US10111956B2 (en) 2013-06-03 2018-10-30 Tolmar, Inc. Corticosteroid compositions
JP6462260B2 (ja) * 2013-07-11 2019-01-30 株式会社ポーラファルマ 泡状外用医薬組成物
RU2016115485A (ru) 2013-09-25 2017-10-30 Сан Фармасьютикал Индастриз Лимитед Композиция галобетазола для местного беспропеллентного спрея
MX2016003951A (es) 2013-09-25 2016-07-06 Sun Pharmaceutical Ind Ltd Composicion para rocio topica de halobetasol.
KR101930244B1 (ko) 2014-03-11 2018-12-18 프로미우스 파마 엘엘씨 국소용 코르티코스테로이드 조성물
US20160184431A1 (en) 2014-03-11 2016-06-30 Promius Pharma Llc Topical compositions comprising a corticosteroid
US9265727B1 (en) 2015-01-14 2016-02-23 Delcor Asset Corporation Spray foam corticosteroid product
US20170000696A1 (en) * 2015-03-24 2017-01-05 The Procter & Gamble Company Methods of applying a high dose of a skin care active to skin with improved sensory benefits to the skin
US20170000711A1 (en) * 2015-03-24 2017-01-05 The Procter & Gamble Company Foam compositions, aerosol products, and methods of using the same to improve sensory benefits to the skin
SG11201805109YA (en) * 2015-12-15 2018-07-30 Therapeutics Inc Halobetasol foam composition and method of use thereof
AU2016372790A1 (en) * 2015-12-15 2018-07-05 Mayne Pharma Llc Corticosteroid containing foam compositions and method of manufacture thereof
US20170340649A1 (en) * 2016-05-30 2017-11-30 Sun Pharmaceutical Industries Limited Topical aqueous spray compositions of halobetasol
US10398641B2 (en) 2016-09-08 2019-09-03 Foamix Pharmaceuticals Ltd. Compositions and methods for treating rosacea and acne
US20190224112A1 (en) * 2018-01-25 2019-07-25 Lupin Atlantis Holdings Sa Methods and Kit for Treating Skin Disorders

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US423695A (en) * 1890-03-18 Sswaxnuttt
US4018918A (en) * 1975-05-20 1977-04-19 The Upjohn Company Topical clindamycin preparations
WO1985001876A1 (en) 1983-10-24 1985-05-09 Lockley Services Pty. Ltd. Foamable biocide composition
EP0190158A1 (en) 1984-06-21 1986-08-13 Soltec Research Pty. Ltd. Aerosol product
US4882182A (en) 1987-01-08 1989-11-21 Soltec Research Pty. Ltd. Aerosol product
US4888354A (en) 1987-12-21 1989-12-19 Theratech, Inc. Skin penetration enhancement using free base and acid addition salt combinations of active agents
AU619256B2 (en) 1988-03-03 1992-01-23 Connetics Australia Pty Ltd Acne treatment
AU629670B2 (en) * 1989-07-28 1992-10-08 Hisamitsu Pharmaceutical Co., Inc. Foamed aerosol preparation
IL95952A0 (en) * 1989-10-19 1991-07-18 Sterling Drug Inc Aerosol composition for topical medicament
EP1382655A3 (en) 1990-09-03 2004-03-10 Connetics Australia Pty Limited A concentrated aerosol space spray
US5935554A (en) 1990-09-03 1999-08-10 Soltec Research Pty. Ltd. Concentrated aerosol space spray that is not an emulsion
ZA94170B (en) 1993-01-20 1995-03-15 Soltec Res Pty Ltd Ectoparasiticidal formulation
DE4446891A1 (de) * 1994-12-27 1996-07-04 Falk Pharma Gmbh Stabile wäßrige Budesonid-Lösung
US5783202A (en) 1995-03-14 1998-07-21 Soltec Research Pty. Ltd. Pediculicidal mousse composition for killing head lice
DK0835098T3 (da) * 1995-06-27 2002-10-07 Boehringer Ingelheim Pharma Stabilt lægemiddelpræparat til frembringlese af drivgasfrie aerosoler
AUPO379596A0 (en) 1996-11-22 1996-12-19 Soltec Research Pty Ltd Percutaneous delivery system
AUPO688997A0 (en) 1997-05-20 1997-06-12 Soltec Research Pty Ltd Sunscreen composition
AUPO983897A0 (en) 1997-10-17 1997-11-06 Soltec Research Pty Ltd Topical antifungal composition
US6231875B1 (en) 1998-03-31 2001-05-15 Johnson & Johnson Consumer Companies, Inc. Acidified composition for topical treatment of nail and skin conditions
AUPP310798A0 (en) 1998-04-22 1998-05-14 Soltec Research Pty Ltd Vehicle system for a composition comprising a piperidinopyrimidine derivative
US6284234B1 (en) 1998-08-04 2001-09-04 Johnson & Johnson Consumer Companies, Inc. Topical delivery systems for active agents
AUPP583198A0 (en) 1998-09-11 1998-10-01 Soltec Research Pty Ltd Mousse composition
US6383471B1 (en) 1999-04-06 2002-05-07 Lipocine, Inc. Compositions and methods for improved delivery of ionizable hydrophobic therapeutic agents
AUPQ002999A0 (en) 1999-04-29 1999-05-20 Soltec Research Pty Ltd Non-aqueous shampoo composition

Also Published As

Publication number Publication date
US6126920A (en) 2000-10-03
EP0813413A1 (en) 1997-12-29
ATE253367T1 (de) 2003-11-15
DK0813413T3 (da) 2004-03-15
US7078058B2 (en) 2006-07-18
BR9607687A (pt) 1999-11-30
AU709320B2 (en) 1999-08-26
PT813413E (pt) 2004-03-31
KR19980702703A (ko) 1998-08-05
SK119097A3 (en) 1998-01-14
CZ275897A3 (cs) 1998-01-14
PL322088A1 (en) 1998-01-05
US20060171898A1 (en) 2006-08-03
HU228890B1 (en) 2013-06-28
NZ302727A (en) 1999-02-25
JP4557310B2 (ja) 2010-10-06
CA2214436C (en) 2007-11-20
WO1996027376A1 (en) 1996-09-12
ES2210349T3 (es) 2004-07-01
HUP9900801A3 (en) 1999-11-29
DE69630593T2 (de) 2004-10-21
US20030118511A1 (en) 2003-06-26
GB9504265D0 (en) 1995-04-19
SK283049B6 (sk) 2003-02-04
CA2214436A1 (en) 1996-09-12
KR100427492B1 (ko) 2004-07-15
AU4885196A (en) 1996-09-23
DE69630593D1 (de) 2003-12-11
EP0813413B1 (en) 2003-11-05
CN1179720A (zh) 1998-04-22
JPH11501045A (ja) 1999-01-26
CN1082817C (zh) 2002-04-17
MX9706698A (es) 1998-06-30
PL183730B1 (pl) 2002-07-31
CZ285913B6 (cs) 1999-11-17

Similar Documents

Publication Publication Date Title
HUP9900801A2 (hu) Kortikoszteroidokat tartalmazó gyógyszerkészítmények
US5990100A (en) Composition and method for treatment of psoriasis
US9180194B2 (en) Method and composition for transdermal drug delivery
US6299900B1 (en) Dermal penetration enhancers and drug delivery systems involving same
AR013614A1 (es) Nueva composicion que comprende una combinacion de esteroides, un kit que la contiene, el uso de la misma, el uso de dicho kit de formoterol y debudesonida en la fabricacion de un medicamento
KR101344342B1 (ko) 경피 약물 전달 방법 및 조성물
GB2332372B (en) Pharmaceutical aerosol compositions
CA2093349A1 (en) Composition containing steroid derivatives
WO1991007974A1 (en) Topical therapeutic preparation
NO980858D0 (no) Farmasöytiske preparater og anordninger for administrering derav
AR021921A1 (es) Formulaciones farmaceuticas en aerosol que contienen fluoroalcanos y budesonido.
KR970032872A (ko) 아세틸살리실산을 함유하는 피부 손상 처치용 약물
BG107257A (en) Formulations containing a glucocorticoid drug for the treatment of bronchopulmonary diseases
JP2776540B2 (ja) 徐起泡型後発泡性組成物
AU9028098A (en) Combinations of endometrial sparing progestins and endometrial atrophizing progestins with estrogens, in oral contraception
CN113286590A (zh) 皮肤外用组合物和气雾剂
JP2001163777A (ja) 皮膚外用液剤
AU2011202787B2 (en) Method and composition for transdermal drug delivery
ALEREBI Topical Formulations and Topical Steroids
AU2006254742B2 (en) Method and composition for transdermal drug delivery
Lassus Local treatment of psoriasis with desoxymethasone and betamethasone 17, 21-dipropionate: a double-blind comparison
JPH0940560A (ja) ステロイド外用剤
HUP0300750A2 (hu) Gesztagéneken alapuló gyógyszerkészítmények dermális alkalmazáshoz